Lyllana
Lyllana is Amneal's branded generic of Minivelle, approved in September 2020 and also sold unbranded. ASHP lists all five strengths as available, which makes it one of the better-supplied twice-a-week patches on paper.
On paper is the point. Medfinder's checks over the last 30 days found Lyllana in stock in about 1% of them (Medfinder). Those checks are made for people who couldn't find it, so they read low, but they show "available" at the maker doesn't mean on your pharmacy's shelf.
- Made by
- Amneal
- Changed
- Twice a week
- Strengths
- 0.025 mg, 0.0375 mg, 0.05 mg, 0.075 mg, 0.1 mg
- FDA approval
- ANDA 211396
- Medfinder in-stock rate
- 1% of 605 checks
Status by strength
| Patch | 0.025 mg | 0.0375 mg | 0.05 mg | 0.075 mg | 0.1 mg |
|---|---|---|---|---|---|
| LyllanaAmneal · twice a week | Available | Available | Available | Available | Available |
- Available
- Limited
- Short
- Discontinued
- No data
Statuses checked October 18, 2026 against each row's source. We re-check every week.
Each strength in detail
0.025 mg (available) · 0.0375 mg (available) · 0.05 mg (available) · 0.075 mg (available) · 0.1 mg (available)
Any change of brand, strength or form is a decision for your prescriber, and your pharmacist can check what they can order.
Get one email when your strength is back
Pick the strength on your box. When ASHP, the makers or Drug Shortages Canada list it as back in normal supply, we write once with what changed.
Sources
- Lyllana label, DailyMed, Amneal, May 15, 2024.
- Drug Shortage Detail: Estradiol Transdermal System, ASHP, August 12, 2026.
- Estradiol shortage tracker, Medfinder, October 18, 2026.
- Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (data files), FDA, October 9, 2026.